
    the study was terminated due to the interim analysis results indicating a weaker correlation
    than anticipated and reported by other study groups.
  
['allergic rhinoconjunctivitis', 'healthy volunteers']
['placebo']

        Inclusion Criteria:

          -  IgE-mediated seasonal allergic rhinitis/rhinoconjunctivitis with or without allergic
             asthma

          -  positive skin prick test

          -  specific IgE ≥ 0.70 kU/L to mixture of grass pollen allergens

          -  symptom score of at least 4 per day during the week following the peak-pollen count in
             the baseline season

        Exclusion Criteria:

          -  undergone previous specific immunotherapy with grass pollen allergens in any
             formulation less than 5 years prior to the screening date

          -  currently undergoing any sort of immunotherapy, or has ever undergone specific
             immunotherapy with unknown allergen

          -  allergens which are expected to interfere with the grass pollen season

          -  uncontrolled or partly controlled asthma

          -  patients with contraindications for SIT
      